Related Experiment Video
Updated: Jan 31, 2026

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
Therapeutic Update on Topical Steroid Withdrawal.
1From the University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.
Topical steroid withdrawal syndrome (TSW) is an iatrogenic condition linked to prolonged corticosteroid use. This review examines current TSW treatments, highlighting the need for evidence-based therapies.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Topical steroid withdrawal syndrome (TSW) is an iatrogenic condition increasingly reported in patients following prolonged topical corticosteroid use.
- TSW is often under-recognized due to lack of formal diagnostic criteria and overlap with atopic dermatitis (AD).
Purpose of the Study:
- To review current and emerging treatments for TSW.
- To provide clinicians and patients with a reference for TSW management options.
- To identify gaps in evidence and call for further research.
Main Methods:
- Literature review of pharmacologic therapies, natural products, lifestyle interventions, and alternative approaches for TSW.
- Analysis of existing clinical evidence for TSW treatments.
Main Results:
- A wide range of treatments are being used or studied for TSW.
- Few TSW treatment strategies are supported by rigorous clinical evidence.
- Current TSW management includes pharmacologic, natural, lifestyle, and alternative therapies.
Conclusions:
- There is a growing need for evidence-based therapies for TSW.
- Further research is required to validate TSW treatment options.
- Clinicians and patients need a clear reference for managing TSW.
Related Concept Videos
Therapeutic Index
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Microorganisms in Medicine and Therapeutics
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Skeletal Muscle Relaxants: Therapeutic Uses

